CClinicalTrials.gg
CompletedNCT06190990Updated Jul 8, 2025

Otago Exercises and Otago Exercise Effects on Elderly Population

An interventional study of Otago Exercise + Exer gaming and exer gaming based programme in Elderly Population, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 55 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
55 Years to 100 Years
Sex
All
01

Study summary

Study aims to investigate the profound impact of exer gaming on normal aged individuals within our society. Additionally, to compare the effects of exer gaming-based exercises and Otago exercises on crucial aspects such as balance, physical performance, and gait pattern among the normal aged population. This study holds immense significance as it has the potential to greatly improve the health and wellbeing of the elderly population. By identifying an efficacious physical therapy intervention to address the complications associated with balance, physical performance, and gait pattern, we can effectively mitigate further dysfunctions in this demographic.

02

Conditions studied

  • Elderly Population

Keywords

  • Exer gaming
  • Otago exercises
  • Distorted balance
  • Disturbed gait
  • Reduce physical performance
  • Older population
03

In context

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Both genders
  • Age > 55 Years
  • Berg balance scale score 21-40
  • Moca >24
  • Urinary bowel continence

Exclusion criteria

Exclusion Criteria:

  • Having history of other neurological conditions (i.e. Dementia, Parkinson's disease)
  • Having contagious or inflammatory conditions.
  • Having orthopedic limitations such as fractures
  • Unable to comply with the training or currently participating in another interfering therapy
  • With Vision problems
  • Having uncontrolled cardiac conditions such as uncontrolled hypertension
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
44 participants (actual)

Study arms

  • Other
    additional effects of exer gaming with otago exercises

    Strengthening training * Sitting knee extension * Standing hip abduction * Standing knee flexion * Tip toe * Heel tiptoe Balance training * Knee bends * Backward walking * Walk in figure 8 * Sideways walking * Tandem stands * Tandem walking * 1-leg stand * Heel walking * Toe walking * Heel-toe walking backward * Sit to stand After Otago exercises, the participants will receive the following exer-gaming based exercises. * Football player * Boat * Volleyball beach

    Other: Otago Exercise + Exer gaming

  • Other
    exer gaming based exercises

    The participants will receive the following exer-gaming based exercises. * Football player * Boat * Volleyball beach

    Other: exer gaming based programme

Interventions

  • OtherOtago Exercise + Exer gaming

    In this group the participant will receive otago exercises and exer-gaming based exercises. The duration of each session this group will receive is of 60 minutes A total of 12 sessions will be held, 3 times a week for 4 weeks. Reading will be taken on baseline, after 2 week

  • Otherexer gaming based programme

    In this group the participant will receive exer-gaming based exercises. The duration of each session this group will receive is of 60 minutes A total of 12 sessions will be held, 3 times a week for 4 weeks. Reading will be taken on baseline, after 2 weeks and then after 4 weeks.

06

What researchers measure

Primary outcomes

  1. Berg balance scale

    Consists of 14 tasks and total score of 56.score of 0-20 indicates severe fall risk, 20-45 includes moderate risk of fall and 45-60 illustrates thr functional balances state.

    Time frame: 4th week

Secondary outcomes

  1. Time Up and Go (TUG)

    The TUG test is a simple assessment used to evaluate a person's mobility and balance. It measures the time it takes for an individual to stand up from a seated position, walk a short distance (typically 3 meters), turn around, walk back, and sit down again. This test is often used to assess the risk of falls among older adults

    Time frame: 4th week

  2. dynamic gait index

    Assess the likelihood of falling in older adults.total score is of 24.score less than 19 is predictive of fall risks.

    Time frame: 4th week

  3. 10 Meter Walk Test (10MWT)

    The 10MWT is a clinical assessment used to measure an individual's walking speed over a 10-meter distance. It is often used to assess gait and mobility, as well as to track changes in a person's walking abilities over time.

    Time frame: 4th week

  4. Montreal Cognitive Assessment

    Montreal Cognitive Assessment (MoCA) is a cognitive assessment tool used to screen for mild cognitive impairment. It assesses various cognitive functions, including memory, attention, language, and visuospatial abilities. It consists of tasks and questions that provide a total score, with lower scores indicating potential cognitive deficits.

    Time frame: 4th week

07

Study locations

1 site
  • RAFSAN Neuro Rehabilitation center
    Peshawar, KPK, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06190990
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jan 5, 2024
Start date
Jan 1, 2024
Primary completion
Dec 30, 2024
Completion
Jan 1, 2025
Last update
Jul 8, 2025

Study contacts

Sara Aabroo, MS NMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion